FUNDING-Novel Genomic Technology Development (R01 Clinical Trial Not Allowed); October 2, 2018

 

Agency:

 

National Human Genome Research Institute

 

Description:

 

This Funding Opportunity Announcement (FOA) seeks grant applications to develop major advances in genomic technologies. Advances in genomics and more broadly in biomedical research have been greatly facilitated by significant and sustained genomics technology throughput increases, cost decreases, and improvements in ease of use. The proposed technology development work should allow comprehensive genomic analysis of features not assayable today, or an increase of no less than an order of magnitude improvement in an existing technology in terms of data quality, throughput, efficiency or comprehensiveness (individually or in combination). This FOA explicitly excludes the development of novel technologies for DNA sequencing and for direct RNA sequencing; those projects should respond to a parallel set of FOAs (RFA-HG-18-001, RFA-HG-18-002, and RFA-HG-18-003).

 

Activity Code:

 

R01

 

Announcement Number

 

PAR-18-777

 

Closing Date:

 

October 2, 2018

 

Link to Full Announcement:

 

http://grants.nih.gov/grants/guide/pa-files/PAR-18-777.html

 

Please note that the program below is also available as:

a R21 (https://grants.nih.gov/grants/guide/pa-files/PAR-18-778.html)

and a R43/R44 (http://grants.nih.gov/grants/guide/pa-files/PAR-18-779.html).